All posts by GTCbio


Ocular Diseases Drug Discovery

GTCbio | November 29th, 2017

By 2050, it is projected that vision loss will grow to affect more than 10 million people, from the current statistic of 4.4 million. The total prevalence of cataract, diabetic retinopathy, glaucoma and AMD is expected to increase to nearly 70 million adults by 2050 which urges to development of drugs for ocular diseases. In…read more